[Infliximab is ineffective against giant cell arteritis and polymyalgia rheumatica].
Krüger
K
K
Praxiszentrum St. Bonifatius, München, St. Bonifatius Strasse 5, 81541 München, Deutschland. klaus.krueger@medinn.med.uni-muenchen.de
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004311:Double-Blind Method; D013700:Giant Cell Arteritis / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D011111:Polymyalgia Rheumatica / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D017211:Treatment Failure
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab; D011241:Prednisone